Acquisition of T790M resistance mutation in a patient with advanced adenocarcinoma harboring uncommon EGFR mutations: a case report and literature review

Taiki Hakozaki, Makiko Yomota Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan Background: Osimertinib is the standard of care for patients with non-small-cell lung cancer (NSCLC) patients harboring a...

Full description

Bibliographic Details
Main Authors: Hakozaki T, Yomota M
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/acquisition-of-t790m-resistance-mutation-in-a-patient-with-advanced-ad-peer-reviewed-article-OTT